gip/glp-1 receptor agonist Science Behind GLP 1 GIP and Glucagon Agonists for Obesity Research | News & Announcements Alimentary Pharmacology & Therapeutics |

J Bone Miner Res (2001) 16(1):1417.10.1359/jbmr.2001.16.1.141 16 BjarnasonNHHenriksenEEAlexandersenPChristgauSHenriksenDBChristiansenC

van EenigeRYingZTramperNWiebingVSirajZde BoerJFet alCombined glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonism attenuates atherosclerosis severity in APOE*3-Leiden.CETP mice

Details and references for each item are discussed in the sections below

Most Do Not Expect Trump Administration to Lower Drug Prices for People Like Them Most of the public has heard little or nothing about recent Trump administration announcement aimed at addressing drug prices, including deals to lower what drug makers charge state Medicaid programs, a deal to lower the cost of in vitro fertilization (IVF) drugs, and plans for a website called TrumpRx that would allow people to buy drugs directly from manufacturers without using their health insurance